| TALI Digital Limited (TD1) ORDINARY FULLY PAID |
Health Care |
$3 |
Trading Halt
|
12 Jun 2025 8:50AM |
$0.001 |
$0.055 |
risen by
5,400%
|
|
TD1 - Price-sensitive ASX Announcement
Full Release
Key Points
- TALI Digital Limited (ASX:TD1) has requested a trading halt on 30 May 2024.
- The trading halt was requested pending an announcement regarding a proposed capital raising.
- The trading halt will remain until either the announcement is made or trading resumes on 3 June 2024.
- The Board of TALI Digital Limited authorized the request for the trading halt.
- The trading halt is meant to ensure an orderly market while material information is being prepared.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$65 |
TNC defines large-scale Cu-Au targets - Salebury, Cloncurry
|
12 Jun 2025 8:48AM |
$0.295 |
$0.425 |
risen by
44.07%
|
|
TNC - Price-sensitive ASX Announcement
Full Release
Key Points
- TNC has defined multiple large-scale Cu-Au targets at the Salebury Project in Cloncurry, North Queensland.
- Advanced geophysical interpretations and recent drilling have refined the understanding of mineralization in the area.
- The targets are interpreted as highly prospective for Iron Oxide Copper Gold (IOCG) systems, similar to other major discoveries in the region.
- The exploration strategy includes further drilling and geophysical surveys to test and refine these targets.
- The company positions these targets as central to its exploration and growth strategy in the Cloncurry district.
- TNC’s technical approach combines historical data with new geoscience techniques to optimize exploration outcomes.
- The announcement highlights the geological potential and strategic value of the Salebury Project.
- Future activities will focus on delineating resources and unlocking further value from the identified targets.
- TNC commits to ongoing exploration and value creation for shareholders through systematic project development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$44 |
Update - Notification of buy-back - IBC
|
12 Jun 2025 8:47AM |
$0.440 |
$0.435 |
fallen by
1.14%
|
|
| Horseshoe Metals Limited (HOR) ORDINARY FULLY PAID |
Materials |
$19 |
Option Exercised - Gold Surface Materials Processing Rights
|
12 Jun 2025 8:47AM |
$0.021 |
$0.026 |
risen by
23.81%
|
|
HOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Horseshoe Metals Limited exercised the option for gold surface materials processing rights at Horseshoe Lights Project.
- The rights cover extraction and processing of gold from surface stockpiles, tailings, and other accessible materials.
- This initiative provides a near-term revenue and cash flow opportunity for the company.
- Details of the option agreement and associated terms are outlined in the announcement.
- Resource estimates and processing potential are discussed, with preliminary assessments indicating significant recoverable gold.
- HOR plans to proceed with operational and regulatory steps to initiate surface materials processing.
- The move supports the company’s broader strategy for project development and shareholder value creation.
- Anticipated timelines, regulatory approvals, and next actions are summarized.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Silver Mines Limited (SVL) ORDINARY FULLY PAID |
Materials |
$388 |
Proposed issue of securities - SVL
|
12 Jun 2025 8:46AM |
$0.125 |
$0.180 |
risen by
44%
|
|
| Peak Minerals Limited (PUA) ORDINARY FULLY PAID |
Materials |
- |
Peak Minerals Ltd - Minta Rutile Project Presentation
|
12 Jun 2025 8:46AM |
$0.019 |
$0.049 |
risen by
157.89%
|
|
| Zeotech Limited (ZEO) ORDINARY FULLY PAID |
Materials |
$154 |
Change in substantial holding
|
12 Jun 2025 8:46AM |
$0.079 |
$0.075 |
fallen by
5.06%
|
|
| Silver Mines Limited (SVL) ORDINARY FULLY PAID |
Materials |
$388 |
Proposed issue of securities - SVL
|
12 Jun 2025 8:44AM |
$0.125 |
$0.180 |
risen by
44%
|
|
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$9 |
Trading Halt
|
12 Jun 2025 8:43AM |
$0.105 |
$0.023 |
fallen by
78.10%
|
|
BTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Butn Limited (BTN) has announced a trading halt on its securities.
- The trading halt is effective from 11 June 2024.
- The purpose of the halt is pending an announcement about a potential capital raising.
- The trading halt will remain until the earlier of either 13 June 2024 or the release of the capital raising announcement.
- The halt aims to ensure a fully informed market and fair trading in BTN securities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,379 |
Investor Forum Presentation Speaker Notes - CEO, CIO and CFO
|
12 Jun 2025 8:43AM |
$71.910 |
$58.230 |
fallen by
19.02%
|
|
| Silver Mines Limited (SVL) ORDINARY FULLY PAID |
Materials |
$388 |
Proposed issue of securities - SVL
|
12 Jun 2025 8:42AM |
$0.125 |
$0.180 |
risen by
44%
|
|
| Silver Mines Limited (SVL) ORDINARY FULLY PAID |
Materials |
$388 |
US Silver-Gold Acquisitions Transform Exploration Portfolio
|
12 Jun 2025 8:42AM |
$0.125 |
$0.180 |
risen by
44%
|
|
SVL - Price-sensitive ASX Announcement
Full Release
Key Points
- Silver Mines Limited (SVL) has acquired a significant portfolio of silver-gold exploration assets in the United States.
- Key projects acquired include Maverick Springs (Nevada), De Soto (Idaho), and Silver King (Arizona).
- The Maverick Springs project boasts a substantial silver-gold resource (inferred and indicated), with exploration upside.
- This marks SVL’s entry into the US precious metals market, diversifying its geographical exposure beyond Australia.
- The acquisition complements SVL’s existing Bowdens Silver Project, strengthening its global portfolio.
- SVL’s strategy is to leverage its technical expertise and enhance future growth through asset diversification.
- The US projects are located in established, stable mining jurisdictions with existing infrastructure.
- Resource estimates and exploration plans for the acquired projects are outlined, emphasizing growth potential.
- SVL highlights the transaction is transformative and aligns with its vision to become a leading global silver producer.
- The announcement details transaction structure, consideration, and next steps for integration and exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,379 |
Investor Forum Presentation Slides
|
12 Jun 2025 8:40AM |
$71.910 |
$58.230 |
fallen by
19.02%
|
|
ASX - Price-sensitive ASX Announcement
Full Release
Key Points
- ASX Limited presented its business and financial overview at the Investor Forum on 14 May 2024.
- The company reported on recent financial results and capital management strategies.
- Key strategic initiatives focus on strengthening core market infrastructure and technology investment.
- Major technology upgrades and projects are underway to enhance operational efficiency and market resilience.
- ASX is actively managing regulatory developments and maintaining transparent communication with stakeholders.
- The company emphasizes long-term value creation and growth opportunities in the Australian financial markets.
- Operational resilience, risk management, and innovation are highlighted as critical priorities.
- ASX remains committed to supporting market integrity and the evolving needs of market participants.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Duxton Water Limited (D2O) ORDINARY FULLY PAID |
Utilities |
- |
Update - Notification of buy-back - D2O
|
12 Jun 2025 8:40AM |
$1.530 |
$1.530 |
fallen by
0%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$40 |
Investor Presentation
|
12 Jun 2025 8:39AM |
$0.040 |
$0.020 |
fallen by
50%
|
|
AGR - Price-sensitive ASX Announcement
Full Release
Key Points
- Aguia Resources Limited (AGR) is focused on developing phosphate projects for agribusiness in southern Brazil.
- The Três Estradas Phosphate Project is AGR’s flagship asset, located in a region with significant agricultural activity.
- Project development has advanced with updated feasibility studies, expanded resource estimates, and improved project economics.
- Key permits and environmental licenses have been obtained, enabling progression toward construction.
- Brazil's heavy reliance on imported phosphate underpins strong domestic demand for AGR’s planned production.
- Phosphate is a critical agricultural input, positioning AGR to supply Brazil’s growing fertilizer market.
- AGR’s strategy includes phased project development, with initial smaller-scale operations expanding over time.
- The company is engaged in securing project financing and strategic partnerships to support development.
- Experienced management and technical teams are guiding project execution.
- Environmental, social, and governance (ESG) considerations are central to AGR’s development philosophy.
- Updates on project milestones, permitting, construction plans, and estimated commissioning timelines are provided.
- The company aims to deliver strong returns to shareholders through disciplined development and market positioning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,507 |
Update - Notification of buy-back - WHC
|
12 Jun 2025 8:38AM |
$5.740 |
$7.890 |
risen by
37.46%
|
|
| ASX Limited (ASX) ORDINARY FULLY PAID |
Financials |
$11,379 |
Investor Forum 2025 and Financial Guidance
|
12 Jun 2025 8:36AM |
$71.910 |
$58.230 |
fallen by
19.02%
|
|
ASX - Price-sensitive ASX Announcement
Full Release
Key Points
- ASX Limited conducted its 2024 Investor Forum outlining strategy, performance, and outlook.
- Emphasis on technology transformation, including CHESS replacement progress and learnings.
- Focus on operational resilience, regulatory compliance, and stakeholder trust.
- Reaffirmation of FY24 financial guidance, with details on revenue and expense expectations.
- Provided FY25 guidance, including operating expense and capital expenditure forecasts.
- Updates on regulatory environment, market trends, and competition landscape.
- Discussion on capital management strategy, dividend policy, and shareholder returns.
- Ongoing commitment to growth, efficiency, and stakeholder engagement.
- Enhanced transparency around major projects, risks, and investment priorities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orora Limited (ORA) ORDINARY FULLY PAID |
Materials |
$1,715 |
Update - Notification of buy-back - ORA
|
12 Jun 2025 8:34AM |
$1.855 |
$1.400 |
fallen by
24.53%
|
|
| Cleo Diagnostics Ltd (COV) ORDINARY FULLY PAID |
Health Care |
$90 |
Corporate Presentation
|
12 Jun 2025 8:33AM |
$0.360 |
$0.655 |
risen by
81.94%
|
|
COV - Price-sensitive ASX Announcement
Full Release
Key Points
- Cleo Diagnostics Ltd is focused on commercializing a blood-based diagnostic test for early detection and risk stratification of ovarian cancer.
- Ovarian cancer has a high mortality rate largely due to late-stage diagnosis and inadequate current diagnostic methods.
- Cleo’s test demonstrates improved sensitivity and specificity over existing diagnostic tools, especially for early-stage ovarian cancer.
- There is a significant unmet clinical need and a multi-billion-dollar global market opportunity for improved ovarian cancer diagnostics.
- The company’s proprietary biomarker panel is scientifically validated with promising clinical trial results.
- Cleo’s regulatory strategy targets CE Mark (Europe), TGA (Australia), and FDA (USA) approvals, with a clear roadmap to market entry.
- The presentation details a go-to-market plan including early adoption by specialist clinicians, payer strategy, and potential global partnerships.
- Competitive advantages include first-mover potential, validated technology, scalable platform, and a strong leadership and advisory team.
- Ongoing and planned clinical studies are designed to further validate test performance and support regulatory submissions.
- Cleo Diagnostics positions itself as a strong investment opportunity with the potential to transform the clinical management of ovarian cancer globally.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$89 |
Update - Notification of buy-back - TOP
|
12 Jun 2025 8:33AM |
$0.635 |
$0.525 |
fallen by
17.32%
|
|
| Bioxyne Limited (BXN) ORDINARY FULLY PAID |
Consumer Staple |
$159 |
FY25 Revenue Guidance Upgrade
|
12 Jun 2025 8:32AM |
$0.026 |
$0.070 |
risen by
169.23%
|
|
BXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Bioxyne Limited (ASX: BXN) upgrades FY25 revenue guidance to between $150 million and $180 million.
- The upgrade is attributed to robust health and wellness business growth in Asia.
- Expansion of distribution channels and increased product demand are key drivers.
- The company is focusing on product innovation and strengthening its supply chain.
- Bioxyne is pursuing new partnership opportunities to support continued growth.
- Initiatives are aimed at reinforcing Bioxyne’s position in the global health and wellness sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brazilian Rare Earths Limited (BRE) ORDINARY FULLY PAID |
Materials |
$1,482 |
Monte Alto Metallurgical Results Deliver High-Purity MREC
|
12 Jun 2025 8:32AM |
$2.140 |
$5.290 |
risen by
147.20%
|
|
BRE - Price-sensitive ASX Announcement
Full Release
Key Points
- Brazilian Rare Earths Limited (BRE) reported successful metallurgical results from Monte Alto project.
- High-purity mixed rare earth carbonate (MREC) was produced with a 99% recovery rate.
- The extraction process used is sulfate-free and environmentally friendly.
- Produced MREC meets or exceeds global purity standards for rare earth separation and the magnet industry.
- Monte Alto demonstrated potential as a major, sustainable rare earths supplier.
- Future plans include further bulk pilot-scale testing and a Pre-Feasibility Study (PFS).
- Project aims to supply high-purity, low-cost magnet rare earths to global markets, providing an alternative to Chinese supply.
- Monte Alto's ionic clay mineralisation is considered significant for rare earth production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$65 |
Update - Notification of buy-back - M7T
|
12 Jun 2025 8:31AM |
$0.320 |
$0.275 |
fallen by
14.06%
|
|
| Nyrada Inc (NYR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$137 |
Notice of Change of Interests of Substantial Holder - M Azzi
|
12 Jun 2025 8:31AM |
$0.175 |
$0.560 |
risen by
220%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$6,533 |
Cochlear launches new cochlear implant system
|
12 Jun 2025 8:30AM |
$270.460 |
$99.890 |
fallen by
63.07%
|
|
Call 1300 880 160
Start a chat
Schedule a call
